121 related articles for article (PubMed ID: 1511119)
1. Measuring proliferation in routine fine needle aspirates. Immunocytochemical detection of bromodeoxyuridine incorporation and Ki-67 expression in breast aspirates.
Buley ID; Morrison EH; Kaklamanis L; Horak E; Gatter KC
Cytopathology; 1992; 3(3):149-54. PubMed ID: 1511119
[TBL] [Abstract][Full Text] [Related]
2. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 staining in histological subtypes of breast carcinoma and fine needle aspiration smears.
Kuenen-Boumeester V; Van Der Kwast TH; Van Laarhoven HA; Henzen-Logmans SC
J Clin Pathol; 1991 Mar; 44(3):208-10. PubMed ID: 1849518
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences.
Gaglia P; Bernardi A; Venesio T; Caldarola B; Lauro D; Cappa AP; Calderini P; Liscia DS
Eur J Cancer; 1993; 29A(11):1509-13. PubMed ID: 8217353
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer.
Billgren AM; Tani E; Liedberg A; Skoog L; Rutqvist LE
Breast Cancer Res Treat; 2002 Jan; 71(2):161-70. PubMed ID: 11881912
[TBL] [Abstract][Full Text] [Related]
6. Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma.
Bozzetti C; Nizzoli R; Naldi N; Manotti L; Savoldi L; Camisa R; Guazzi A; Cocconi G
Breast Cancer Res Treat; 1994; 32(2):221-8. PubMed ID: 7865851
[TBL] [Abstract][Full Text] [Related]
7. Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.
Camplejohn RS; Brock A; Barnes DM; Gillett C; Raikundalia B; Kreipe H; Parwaresch MR
Br J Cancer; 1993 Apr; 67(4):657-62. PubMed ID: 7682430
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical evaluation of proliferative activity in human brain tumours.
Girino M; Riccardi A; Danova M; Gaetani P; Butti G; Giordano M; Cuomo A
Anal Cell Pathol; 1990 Sep; 2(5):269-75. PubMed ID: 2275874
[TBL] [Abstract][Full Text] [Related]
9. Proliferation index as a prognostic marker in breast cancer.
Veronese SM; Gambacorta M; Gottardi O; Scanzi F; Ferrari M; Lampertico P
Cancer; 1993 Jun; 71(12):3926-31. PubMed ID: 8508358
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression.
Danova M; Pellicciari C; Zibera C; Mangiarotti R; Gibelli N; Giordano M; Wang E; Mazzini G; Riccardi A
Ann N Y Acad Sci; 1993 Nov; 698():174-81. PubMed ID: 7904138
[TBL] [Abstract][Full Text] [Related]
11. Cytologic assessment of tumor cell kinetics: applications of monoclonal antibody Ki-67 to fine-needle aspiration smears.
Henry MJ; Stanley MW; Swenson B; Connolly JE; Bates H
Diagn Cytopathol; 1991; 7(6):591-6. PubMed ID: 1769287
[TBL] [Abstract][Full Text] [Related]
12. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
13. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ
Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
15. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
16. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI
J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
[TBL] [Abstract][Full Text] [Related]
17. Proliferation markers in breast cancer.
Silvestrini R
Eur J Cancer; 1993; 29A(11):1501-2. PubMed ID: 8217350
[No Abstract] [Full Text] [Related]
18. Fine needle aspiration techniques for the characterization of breast cancers.
Ljung BM; Chew K; Deng G; Matsumura K; Waldman F; Smith H
Cancer; 1994 Aug; 74(3 Suppl):1000-5. PubMed ID: 8039133
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Parkins CS; Bush C; Price P; Steel GG
Cell Prolif; 1991 Mar; 24(2):171-9. PubMed ID: 2009320
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical detection of carcinoembryonic antigen in fine-needle aspirates from patients with diverse breast diseases.
Alexiev BA; Valkov IN; Popov AA; Marinov VS
Diagn Cytopathol; 1993 Aug; 9(4):377-82. PubMed ID: 8261842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
